Sangeetha Venugopal, MD, MS, discussed the evolving landscape of acute myeloid leukemia treatment as well as unmet needs ...

A new study aims to investigate the feasibility and impact of multidisciplinary prehabilitation in adults with acute myeloid ...

As highlighted by a 2017 report, Hispanic patients with AML have shorter survival outlooks and younger ages of presentation ...

According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or ...

Before receiving treatment for acute myeloid leukemia, I made it a point to take advantage of all the resources that were ...

The bioengineering company Ossium Health has created a new program that offers deep-frozen bone marrow from deceased organ donors -- and a Michigan woman has received the first transplant.

Positive preliminary outcomes were reported for the first leukemia patient treated with Ossium Health's organ donor bone ...

Davis is able to focus on different numbers now. A linebacker, Davis ranks third on the team with 12 tackles. Last week, ...

Phase II trial of the novel combination, decitabine, venetoclax, and ponatinib achieved bone marrow remission in 80% of ...

ICT01 showed tolerable safety and promising clinical activity as a monotherapy and is now being investigated in combination ...

According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or ...